Morgan Stanley files Form 144 to offer 2,883 ACLS shares
Morgan Stanley Smith Barney LLC filed a Form 144 proposing the sale of 2,883 shares of Common Stock of ACLS.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Morgan Stanley Smith Barney LLC filed a Form 144 proposing the sale of 2,883 shares of Common Stock of ACLS. The filing lists restricted stock vesting entries tied to the issuer on 06/15/2023, 05/16/2023, 06/15/2022, and 09/15/2023 with quantities 1,766, 453, 166, and 498 respectively.
The form shows an aggregate figure of $463,730.55 and a separate numeric field 30,719,000 as presented on the form. The filing lists NASDAQ as the market and Morgan Stanley Smith Barney LLC as the filer at the New York Plaza address.
Insights
Routine Form 144 notice for proposed broker-facilitated sales of vested restricted shares.
The filing records a proposed sale notice by Morgan Stanley Smith Barney LLC for 2,883 shares of Common Stock and shows multiple vesting events dated 06/15/2023, 05/16/2023, 06/15/2022, and 09/15/2023
Timing, method of sale, and final execution details are not included in the excerpt; subsequent SEC filings or broker confirmations would show completion or disposition details.
Key Figures
Key Terms
Form 144 regulatory
restricted stock vesting financial
Issuer regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does ACLS Form 144 filed by Morgan Stanley Smith Barney LLC report?
Does the Form 144 disclose proceeds or aggregate dollar amounts for the ACLS sale?
Who is the filer and on which market is ACLS listed in this Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.
Keep reading
More on ACLS
- Sep 21, 2026 Axcelis Announces Sponsorship and Participation in the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026)
- Sep 14, 2026 Axcelis Announces Sponsorship and Participation in the 25th International Conference on Ion Implantation and Annealing Technology 2026
- Sep 8, 2026 Axcelis to Build New Manufacturing Facility in Pyeongtaek, Korea